Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:ADUS NASDAQ:AMED NYSE:CHE NASDAQ:OPCH On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeADUSAddus HomeCare$99.57+2.3%$97.85$90.89▼$124.43$1.82B0.92262,606 shs253,777 shsAMEDAmedisys$101.01+0.0%$99.72$92.44▼$101.02$3.32B0.89509,062 shs1.06 million shsCHEChemed$424.48-0.3%$396.39$365.20▼$583.96$5.65B0.54266,612 shs152,413 shsOPCHOption Care Health$20.51-1.2%$28.29$18.01▼$36.80$3.26B0.683.59 million shs4.30 million shs10 Best Stocks to Own in 2026Enter your email address and we’ll send you MarketBeat’s list of ten stocks set to soar in Spring 2026, despite the threat of tariffs and what's happening in Iran. These ten stocks are incredibly resilient and are likely to thrive in any economic environment. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceADUSAddus HomeCare+0.67%+0.41%+4.44%-8.11%-13.33%AMEDAmedisys0.00%0.00%0.00%0.00%+5.01%CHEChemed+0.07%+0.04%+9.50%-4.95%-26.31%OPCHOption Care Health+1.47%+2.07%-25.20%-38.97%-37.95%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeADUSAddus HomeCare$99.57+2.3%$97.85$90.89▼$124.43$1.82B0.92262,606 shs253,777 shsAMEDAmedisys$101.01+0.0%$99.72$92.44▼$101.02$3.32B0.89509,062 shs1.06 million shsCHEChemed$424.48-0.3%$396.39$365.20▼$583.96$5.65B0.54266,612 shs152,413 shsOPCHOption Care Health$20.51-1.2%$28.29$18.01▼$36.80$3.26B0.683.59 million shs4.30 million shs10 Best Stocks to Own in 2026Enter your email address and we’ll send you MarketBeat’s list of ten stocks set to soar in Spring 2026, despite the threat of tariffs and what's happening in Iran. These ten stocks are incredibly resilient and are likely to thrive in any economic environment. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceADUSAddus HomeCare+0.67%+0.41%+4.44%-8.11%-13.33%AMEDAmedisys0.00%0.00%0.00%0.00%+5.01%CHEChemed+0.07%+0.04%+9.50%-4.95%-26.31%OPCHOption Care Health+1.47%+2.07%-25.20%-38.97%-37.95%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceADUSAddus HomeCare 2.73Moderate Buy$132.3332.90% UpsideAMEDAmedisys 0.00N/AN/AN/ACHEChemed 2.33Hold$501.5018.15% UpsideOPCHOption Care Health 2.83Moderate Buy$31.2552.36% UpsideCurrent Analyst Ratings BreakdownLatest AMED, CHE, OPCH, and ADUS Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/6/2026OPCHOption Care Health Morgan StanleySubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingSet Price Target$28.005/6/2026ADUSAddus HomeCare Citizens JmpSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetMarket Outperform$150.00 ➝ $142.005/6/2026OPCHOption Care Health Morgan StanleySubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingOverweight5/4/2026OPCHOption Care Health JPMorgan Chase & Co.Subscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetOverweight$40.00 ➝ $33.005/1/2026OPCHOption Care Health Truist FinancialSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingSet Price Target$30.005/1/2026OPCHOption Care Health Barrington ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetOutperform$42.00 ➝ $32.005/1/2026OPCHOption Care Health UBS GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetBuy$45.00 ➝ $39.005/1/2026OPCHOption Care Health StephensSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingSet Price Target$30.005/1/2026OPCHOption Care Health Deutsche Bank AktiengesellschaftSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy$26.005/1/2026OPCHOption Care Health TD CowenSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetHold$37.00 ➝ $23.005/1/2026OPCHOption Care Health Bank of AmericaSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeBuy ➝ Neutral$22.00(Data available from 5/8/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookADUSAddus HomeCare$1.42B1.31$6.65 per share14.98$59.80 per share1.67AMEDAmedisys$2.40B1.38$6.24 per share16.20$38.77 per share2.61CHEChemed$2.53B2.23$24.59 per share17.26$63.88 per share6.64OPCHOption Care Health$5.65B0.57$2.02 per share10.16$8.60 per share2.38Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateADUSAddus HomeCare$95.91M$5.4118.4014.841.346.89%9.80%7.34%N/AAMEDAmedisys$43.23M$2.5739.3020.871.343.56%12.91%7.29%N/ACHEChemed$265.24M$18.3523.1316.661.6010.23%27.18%17.38%N/AOPCHOption Care Health$207.59M$1.2915.9011.031.143.64%18.17%7.16%N/ALatest AMED, CHE, OPCH, and ADUS EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/4/2026Q1 2026ADUSAddus HomeCare$1.52$1.62+$0.10$1.36$366.41 million$363.50 million4/30/2026Q1 2026OPCHOption Care Health$0.37$0.40+$0.03$0.29$1.39 billion$1.35 billion4/23/2026Q1 2026CHEChemed$5.30$5.65+$0.35$4.84$659.22 million$657.51 million2/25/2026Q4 2025CHEChemed$7.02$6.42-$0.60$5.48$659.09 million$639.34 million2/24/2026Q4 2025OPCHOption Care Health$0.46$0.46N/A$0.37$1.46 billion$1.47 billionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthADUSAddus HomeCareN/AN/AN/AN/AN/AAMEDAmedisysN/AN/AN/AN/AN/ACHEChemed$2.400.57%+10.76%13.08%16 YearsOPCHOption Care HealthN/AN/AN/AN/AN/ALatest AMED, CHE, OPCH, and ADUS DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date2/13/2026CHEChemedquarterly$0.600.5%2/23/20262/23/20263/13/2026(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioADUSAddus HomeCare0.081.831.80AMEDAmedisys0.261.361.36CHEChemed0.110.850.83OPCHOption Care Health0.851.641.07Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipADUSAddus HomeCare95.35%AMEDAmedisys94.36%CHEChemed95.85%OPCHOption Care Health98.05%Insider OwnershipCompanyInsider OwnershipADUSAddus HomeCare4.50%AMEDAmedisys2.10%CHEChemed3.33%OPCHOption Care Health1.70%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableADUSAddus HomeCare50,65918.67 million17.83 millionOptionableAMEDAmedisys20,00032.89 million32.20 millionOptionableCHEChemed15,81113.27 million12.83 millionOptionableOPCHOption Care Health8,266157.03 million154.36 millionOptionableAMED, CHE, OPCH, and ADUS HeadlinesRecent News About These CompaniesOption Care Health, Inc. (NASDAQ:OPCH) Receives Average Recommendation of "Moderate Buy" from AnalystsMay 8 at 2:45 AM | americanbankingnews.comOption Care Health, Inc. (NASDAQ:OPCH) Given Average Recommendation of "Moderate Buy" by BrokeragesMay 8 at 2:43 AM | marketbeat.comInsider Buying: Option Care Health (NASDAQ:OPCH) Director Acquires 24,154 Shares of StockMay 7 at 6:38 PM | marketbeat.comThe top 5 analyst questions from Option Care Health’s Q1 earnings callMay 7 at 5:18 PM | msn.comSecurities Fraud Investigation Into Option Care Health, Inc. (OPCH) Announced - Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading ...May 7 at 5:18 PM | tmcnet.comINVESTOR ALERT: Investigation of Option Care Health, Inc. (OPCH) announced by Holzer & Holzer, LLCMay 7 at 3:34 PM | globenewswire.comOPCH SHAREHOLDER INVESTIGATION: Levi & Korsinsky Investigates Option Care Health for Possible Securities Law ViolationsMay 7 at 9:00 AM | globenewswire.comOption Care Health Investors Should Contact Block & Leviton to Possibly Recover LossesMay 7 at 8:15 AM | newsfilecorp.comNSwedbank AB Sells 55,532 Shares of Option Care Health, Inc. $OPCHMay 7 at 6:52 AM | marketbeat.comHarry Jansen Kraemer, Jr. Purchases 36,610 Shares of Option Care Health (NASDAQ:OPCH) StockMay 7 at 5:01 AM | americanbankingnews.comOption Care Health's (OPCH) Overweight Rating Reaffirmed at Morgan StanleyMay 7 at 4:25 AM | americanbankingnews.comOPCH Investors Have Opportunity to Join Option Care Health, Inc. Fraud Investigation with the ...May 6 at 8:52 PM | caledonianrecord.comCOption Care Health, Inc. (OPCH) Shareholders Who Lost Money - Contact Law Offices of Howard G. Smith About Securities Fraud InvestigationMay 6 at 8:52 PM | tmcnet.comOPCH Investors Have Opportunity to Join Option Care Health, Inc. Fraud Investigation with the Schall Law FirmMay 6 at 6:15 PM | globenewswire.comOption Care Health, Inc. (OPCH) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud InvestigationMay 6 at 4:53 PM | businesswire.comSecurities Fraud Investigation Into Option Care Health, Inc. (OPCH) Announced - Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. CruzMay 6 at 3:51 PM | tmcnet.comOption Care Health (NASDAQ:OPCH) Earns Overweight Rating from Morgan StanleyMay 6 at 3:01 PM | marketbeat.comOngoing Securities Investigation into Option Care Health, Inc. (OPCH) - Contact Levi & KorsinskyMay 6 at 2:42 PM | newsfilecorp.comNSecurities Fraud Investigation Into Option Care Health, Inc. (OPCH) Announced – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. CruzMay 6 at 2:23 PM | businesswire.comOption Care Health Investigation Initiated: Levi & Korsinsky Investigates the Officers and Directors of Option Care Health (OPCH)May 6 at 9:00 AM | prnewswire.comInsider Buying: Option Care Health (NASDAQ:OPCH) Director Buys 36,610 Shares of StockMay 6 at 6:03 AM | insidertrades.comNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All Headlines3 Dividend Aristocrats Whose Yields Can Help Combat InflationBy Chris Markoch | April 9, 2026The Real SpaceX Play: 5 Chip Stocks Powering the IPO Before It LaunchesBy Bridget Bennett | May 4, 2026NVIDIA's Quantum Computing Play Just Sent IonQ and Rigetti Flying By Jeffrey Neal Johnson | April 15, 2026AI, Satellites and Staples: Insiders Are Buying and Selling 3 Big NamesBy Leo Miller | April 13, 2026This 4/20, Wall Street Is Betting on More Than MarijuanaBy Jeffrey Neal Johnson | April 20, 2026AMED, CHE, OPCH, and ADUS Company DescriptionsAddus HomeCare NASDAQ:ADUS$99.57 +2.28 (+2.34%) Closing price 04:00 PM EasternExtended Trading$99.57 0.00 (0.00%) As of 06:16 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health. The Personal Care segment provides non-medical assistance with activities of daily living. This segment offers services that include assistance with bathing, grooming, oral care, feeding and dressing, medication reminders, meal planning and preparation, housekeeping, and transportation services. The Hospice segment provides palliative nursing care, social work, spiritual counseling, homemaker, and bereavement counseling services for people who are terminally ill, as well as related services for their families. The Home Health segment offers skilled nursing and physical, occupational, and speech therapy for the individuals who requires assistance during an illness or after hospitalization. The company's payor clients include federal, state, and local governmental agencies; managed care organizations; commercial insurers; and private individuals. Addus HomeCare Corporation was founded in 1979 and is headquartered in Frisco, Texas.Amedisys NASDAQ:AMEDAmedisys, Inc., together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients. The Hospice segment offers services that is designed to provide comfort and support for those who are dealing with a terminal illness, including cancer, heart disease, pulmonary disease, or Alzheimer's. The High Acuity Care offers essential elements of inpatient hospital, skilled nursing facility care, and palliative care to patients in their homes. Amedisys, Inc. was incorporated in 1982 and is headquartered in Baton Rouge, Louisiana.Chemed NYSE:CHE$424.48 -1.34 (-0.32%) Closing price 03:59 PM EasternExtended Trading$424.31 -0.17 (-0.04%) As of 05:40 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees. The company was incorporated in 1970 and is headquartered in Cincinnati, Ohio.Option Care Health NASDAQ:OPCH$20.51 -0.24 (-1.16%) Closing price 04:00 PM EasternExtended Trading$20.51 0.00 (0.00%) As of 07:07 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Option Care Health, Inc. offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders. It also offers treatments to manage the progression of neurological disorders, such as multiple sclerosis, duchenne muscular dystrophy, and other neurological disorder; infusion therapies for bleeding disorders, such as hemophilia and von Willebrand diseases; therapies for women with high-risk pregnancies; and other infusion therapies to treat various conditions, including pain management, chemotherapy, and respiratory medications, as well as nursing services. The company markets its services through patient referrals, including physicians, hospital discharge planners, hospital personnel, health maintenance organizations, and preferred provider organizations. Option Care Health, Inc. is headquartered in Bannockburn, Illinois. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas SoundHound’s Bottom Is In—Inflection and 50% Upside Ahead? Rocket Lab Posts Record Q1 Revenue, Raises Q2 Guidance Hims & Hers Earnings Preview: The Novo Nordisk Shift Puts GLP-1 Strategy in Focus AppLovin Pops After Earnings With Growth Catalysts in Sight Dutch Bros Q1 Earnings: The Newest Starbucks Rival Faces Its First Big Reality Check The AI Fear Around Datadog Stock May Have Been Completely Wrong Amprius Technologies Ups the Voltage on Forward Outlook Why Lam Research Still Looks Like a Buy After a 300% Rally Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
